Figure S7 from EZH2 Suppression Diversifies Prostate Cancer Lineage Variant Evolution and Lacks Efficacy in Inhibiting Disease Progression
Abstract
AR genome binding patterns and transcriptional effects are altered in Ezh2 deficient PrCa
Fields of Study & Subjects
Prostate Cancer Treatment and Research
Epigenetics and DNA Methylation
Chromatin Remodeling and Cancer
Publication details
- Publication date
- 16 February 2026
- Language
- EN